Bronchiectasis « Medical Search of the Day
Links shared publicly online about this topic.
- 1,056total visits
Bronchiectasis « Medical Search of the Day
medicalsearchoftheday.wordpress.com —
View full resource at medicalsearchoftheday.wordpress.com
Tags: Nose, Sinus, Lung, Bronchiectasis
Most Recently Shared on June 30, 2010 at 2:55 pm By:
Bronchiectasis: The chronic lung and sinus inflammation known as bronchiectasis has nearly vanished in wealthier n... http://bit.ly/ddUZPA
Jane’s Digest—Bronchiectasis: I’m Still Here | COPD Foundation Blog
blog.copdfoundation.org — “This is the third part in a series. It was written by Jon Haas, who lost his wife Jane March 26, 2009 to Bronchiectasis. The start of Jane’s final battle” View full resource at blog.copdfoundation.org
Most Recently Shared on March 30, 2012 at 2:49 pm By:
COPD Foundation Health Organization
A new COPD post: Jane’s Digest—Bronchiectasis: I’m Still Here: This is the third part in a series. It was writte... http://t.co/siy9bBFI
Jane’s Digest—Bronchiectasis: Fighting to the Very End | COPD Foundation Blog
blog.copdfoundation.org — “This is the second part in a series. It was written by Jon Haas, who lost his wife Jane March 26, 2009 to Bronchiectasis. Upon examination in 1995/1996 in” View full resource at blog.copdfoundation.org
Most Recently Shared on March 23, 2012 at 12:20 pm By:
COPD Foundation Health Organization
A new COPD post: Jane’s Digest—Bronchiectasis: Fighting to the Very End: This is the second part in a series. It... http://t.co/OEDAffGg
Jane’s Digest–Bronchiectasis: The Start | COPD Foundation Blog
blog.copdfoundation.org — “This is the first part in a series that we’ll feature on our blog every Friday for the next couple weeks. This blog post was written by Jon Haas, who lost his” View full resource at blog.copdfoundation.org
Most Recently Shared on March 16, 2012 at 3:18 pm By:
COPD Foundation Health Organization
A new COPD post: Jane’s Digest–Bronchiectasis: The Start: This is the first part in a series that we’ll feature ... http://t.co/6EuJ2XJD
COPD Foundation Announces Landmark Measure: 1,000th Patient Enrolled in Bronchiectasis Research Registry | Business Wire
businesswire.com — “With Chronic Obstructive Pulmonary Disease (COPD) as the third leading cause of death in the United States and the only chronic disease growing in mor” View full resource at businesswire.com
Most Recently Shared on October 20, 2011 at 3:39 pm By:
OrganizedWisdom COPD OW Health
COPD Foundation Announces Landmark Measure: 1,000th Patient Enrolled in Bronchiectasis Research Registry: WASHIN... http://t.co/YASHMcV3
COPD Foundation Announces Landmark Measure: 1,000th Patient Enrolled in Bronchiectasis Research Registry - MarketWatch
marketwatch.com — “COPD Foundation Announces Landmark Measure: 1,000th Patient Enrolled in Bronchiectasis Research Registry - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on October 20, 2011 at 2:24 pm By:
Devonsuperstore Health Business
COPD Foundation Announces Landmark Measure: 1,000th Patient Enrolled in Bronchiectasis Research Registry http://t.co/P1R9HG8y
New ACCP Resources | The American College of Chest Physicians
chestnet.org — “New ACCP Resources | The American College of Chest Physicians” View full resource at chestnet.org
Most Recently Shared on September 21, 2011 at 8:15 pm By:
Earn free CME credit with PCCSU. Non-cystic fibrosis bronchiectasis is the topic. http://ow.ly/6AxT1
Hypertonic saline for bronchiectasis | Practice | Nursing Times
nursingtimes.net — “A nurse-led initiative has demonstrated that nebulised hypertonic saline can help patients with bronchiectasis to clear secretions, improving their quality of life” View full resource at nursingtimes.net
Most Recently Shared on August 4, 2011 at 11:35 am By:
Latest practice: Hypertonic saline for bronchiectasis http://bit.ly/pxBBru
Infectious Disease Article | Pneumonia
mdlinx.com — “First Case of Segniliparus rotundus Pneumonia in a Patient with Bronchiectasis” View full resource at mdlinx.com
Most Recently Shared on July 18, 2011 at 11:32 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
First Case of Segniliparus rotundus Pneumonia in a Patient with Bronchiectasis: Journal of Clinical Microbiology http://bit.ly/oSvwx3 #ID
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study With Inhaled Liposomal Ciprofloxacin
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) (the Company) today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment - ORB” View full resource at medicalnewstoday.com
Most Recently Shared on June 17, 2011 at 4:05 pm By:
MNT Cystic Fibrosis Health News
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study With Inhaled Liposomal Ciprofloxacin http://mnt.to/3Xmt #cysticfibrosis
Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis
news-medical.net — “Aradigm Corporation today announced positive top line data from its recently concluded Phase 2b study (Once-Daily Respiratory Bronchiectasis Inhalation Treatment - ORBIT-1) with Aradigm's ciprofloxacin for inhalation (CFI, ARD-3100, LipoquinTM) in patients with non-cystic fibrosis bronchiectasis (BE).” View full resource at news-medical.net
Most Recently Shared on June 16, 2011 at 1:40 pm By:
Aradigm demonstrates top line data from ORBIT-1 ARD-3100 Phase 2b study for bronchiectasis: Aradigm Corporation ... http://bit.ly/m6m5x4
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin - Drugs.com MedNews
drugs.com — “Both ARD-3100 Doses Met Primary Endpoint 2 mL Dose Found Equipotent to 3 mL Dose, with Excellent Safety and Tolerability Jun 16, 2011 - Aradigm Corporation (OTC” View full resource at drugs.com
Most Recently Shared on June 16, 2011 at 1:08 pm By:
Drugs and Devices OW OW Health
Aradigm Reports Successful ORBIT-1 Bronchiectasis Study with Inhaled Liposomal Ciprofloxacin: Both ARD-310... http://bit.ly/mBxNZC #drug
Aradigm Receives FDA Orphan Drug Designation For Ciprofloxacin For Inhalation In Bronchiectasis
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) (the Company) today announced it has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for ciprofloxacin for inhalation for the m” View full resource at medicalnewstoday.com
Most Recently Shared on June 7, 2011 at 3:05 pm By:
MNT Cystic Fibrosis Health News
Aradigm Receives FDA Orphan Drug Designation For Ciprofloxacin For Inhalation In Bronchiectasis http://mnt.to/3WSg #cysticfibrosis
NTM Info & Research | Facebook
facebook.com — “NTM Info & Research - Information about research and health for NTM lung disease and NTM-related diseases like CF, bronchiectasis and PCD. | Facebook” View full resource at facebook.com
Most Recently Shared on June 1, 2011 at 4:04 pm By:
Philip Leitman - NTM Info & Research Support
Have you liked us on Facebook yet? http://www.facebook.com/pages/NTM-Info-Research/20971945418
Bronchiectasis | Serrapeptase.info
serrapeptase.info — “Bronchiectasis | Serrapeptase.info” View full resource at serrapeptase.info
Most Recently Shared on April 8, 2011 at 7:37 pm By:
In Oct. of 2009, Sue became a Certified Natural Health Professional, and
in 2011 became Certified as a Digestive Health Specialist through the
Loomis Institute of Enzyme Nutrition, and is also a member of the
American Holistic Nurses Association. Sue has a private practice in
Green Bay, WI., but has the priviledge of having and serving clients in
areas of Nova Scotia, Boston, Minnesota, West Virginia, and the Fox
Valley area of WI. She maintains her current WI Nursing Licensure. We welcome you to
contact us about cancer-fighting supplements used in Sue's treatment.
" /> Suzan Macco RN, CNHP, Loomis Digestive Health Specialist Nurse and Active Health Library
Bronchiectasis & Serrapeptase http://bit.ly/eI5bLN
Aradigm Completes Enrollment In Phase 2b Study Of Inhaled Ciprofloxacin For The Management Of Respiratory Infections In Bronchiectasis
medicalnewstoday.com — “Aradigm Corporation (OTCBB:ARDM) announced the last patient was enrolled in a Phase 2b study designed to evaluate the Company's inhaled liposomal ciprofloxacin (CFI, ARD-3100) in patients with non” View full resource at medicalnewstoday.com
Most Recently Shared on March 23, 2011 at 4:05 pm By:
MNT Cystic Fibrosis Health News
Aradigm Completes Enrollment In Phase 2b Study Of Inhaled Ciprofloxacin For The Management Of Respiratory Infections I... http://mnt.to/3SDy
Advertisement
